P1736: CHARACTERISTICS, HEALTHCARE UTILIZATION, AND COSTS ASSOCIATED WITH INOTUZUMAB OZOGAMICIN, BLINATUMOMAB, OR OTHER AGENTS FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales: Russell-Smith, A., Shah, R., Silverstein, A., Petrilla, A., Leinwand, B., Norris, D., Schroeder, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429691/
http://dx.doi.org/10.1097/01.HS9.0000849800.15938.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429691/
http://dx.doi.org/10.1097/01.HS9.0000849800.15938.16

Ejemplares similares